OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacokinetics of tenofovir during pregnancy and postpartum.
Published in:
HIV Medicine, 2015, v. 16, n. 8, p. 502, doi. 10.1111/hiv.12252
By:
- Best, BM;
- Burchett, S;
- Li, H;
- Stek, A;
- Hu, C;
- Wang, J;
- Hawkins, E;
- Byroads, M;
- Watts, DH;
- Smith, E;
- Fletcher, CV;
- Capparelli, EV;
- Mirochnick, M
Publication type:
Article
Alteration in cytochrome P450 3 A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.
Published in:
HIV Medicine, 2015, v. 16, n. 3, p. 176, doi. 10.1111/hiv.12195
By:
- Aweeka, FT;
- Hu, C;
- Huang, L;
- Best, BM;
- Stek, A;
- Lizak, P;
- Burchett, SK;
- Read, JS;
- Watts, H;
- Mirochnick, M;
- Capparelli, EV
Publication type:
Article
Effect of pregnancy on emtricitabine pharmacokinetics.
Published in:
HIV Medicine, 2012, v. 13, n. 4, p. 226, doi. 10.1111/j.1468-1293.2011.00965.x
By:
- Stek, AM;
- Best, BM;
- Luo, W;
- Capparelli, E;
- Burchett, S;
- Hu, C;
- Li, H;
- Read, JS;
- Jennings, A;
- Barr, E;
- Smith, E;
- Rossi, SS;
- Mirochnick, M
Publication type:
Article
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.
Published in:
2008
By:
- Read JS;
- Best BM;
- Stek AM;
- Hu C;
- Capparelli EV;
- Holland DT;
- Burchett SK;
- Smith ME;
- Sheeran EC;
- Shearer WT;
- Febo I;
- Mirochnick M
Publication type:
Journal Article
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
Published in:
2013
By:
- Croteau D;
- Rossi SS;
- Best BM;
- Capparelli E;
- Ellis RJ;
- Clifford DB;
- Collier AC;
- Gelman BB;
- Marra CM;
- McArthur J;
- McCutchan JA;
- Morgello S;
- Simpson DM;
- Grant I;
- Letendre S;
- CHARTER Group;
- Croteau, David;
- Rossi, Steven S;
- Best, Brookie M;
- Capparelli, Edmund
Publication type:
journal article

Found: 5

Pharmacokinetics of tenofovir during pregnancy and postpartum.

Alteration in cytochrome P450 3 A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.

Effect of pregnancy on emtricitabine pharmacokinetics.

Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.